Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib. - Concepedia

Concepedia

Publication | Closed Access

Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib.

24

Citations

0

References

2016

Year

Ondřej Fiala, Miloš Pešek, Jindřich Fínek, Ondřej Topolčan, Jaroslav Ráček, Martin Svatoň, Radek Kučera, Marek Minárik, Lucie Benešová, Zbyněk Bortlíček,

Abstract

LDH is a commonly used serum biomarker, that is cheap and easy to detect. The results of our study suggest that the change in LDH serum level during the first month is a surrogate marker on the efficacy of erlotinib in patients with advanced NSCLC.